Skip to main content
Top
Published in: International Journal of Colorectal Disease 1/2018

01-01-2018 | Original Article

Population-based screening improves histopathological prognostic factors in colorectal cancer

Authors: Mónica Mengual-Ballester, Enrique Pellicer-Franco, Graciela Valero-Navarro, Victoriano Soria-Aledo, José Andrés García-Marín, José Luis Aguayo-Albasini

Published in: International Journal of Colorectal Disease | Issue 1/2018

Login to get access

Abstract

Introduction

Diagnosis of colorectal cancer (CRC) based on clinical symptoms is usually established in its advanced stages. One strategy for reducing mortality is the early detection and removal of preneoplastic and initial neoplastic lesions, even before the first symptoms appear, by means of population-based screening campaigns. The aim of the present study is to determine whether CRC diagnosed via a screening campaign has more favourable histopathological prognostic factors than when diagnosed in the symptomatic phase.

Material and methods

The prospective study of all the patients undergoing programmed CRC surgery at the JM Morales Meseguer Hospital (Spain) is between 2004 and 2010. The patients were divided into two groups: one diagnosed from clinical symptoms and one through a screening campaign. The following factors were compared: tumour size; degree of tumour invasion of the wall; lymph node, perineural and lymphovascular involvement; tumour stage; and grade of differentiation.

Results

Compared to the symptomatic group, the screen-detected patients had smaller-sized tumours (lesions of less than 5 cm in 84 vs 69.55%, p < 0.001), a lower degree of colorectal wall invasion (T0–1 in 36 vs 9.02%, p < 0.001), less lymph node involvement (N0 in 72 vs 58.76%, p > 0.05), less vascular invasion (7.20 vs 15.22%, p = 0.79) and less perineural invasion (6.4 vs 20.70%, p < 0.001). The TNM staging in the screening group was lower than in the symptomatic group (stage 0–1 in 50.40 vs 18.58%, p < 0.001).

Conclusions

CRC diagnosed through a population-based screening programme presents more favourable histopathological characteristics than that diagnosed from the appearance of symptoms.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mather C et al (2013) GLOBOCAN 2012 v 1.0. Cancer incidence and mortality worldwide: IARC Cancer Base. No. 11. Lyon, France: International Agency for Research on. Cancer Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mather C et al (2013) GLOBOCAN 2012 v 1.0. Cancer incidence and mortality worldwide: IARC Cancer Base. No. 11. Lyon, France: International Agency for Research on. Cancer
2.
go back to reference Bujanda L, Sarasqueta C, Hijona E, Hijona L, Cosme A, Gil I, Elorza JL et al (2010) Colorectal cancer prognosis twenty years later. World J Gastroenterol 16:862–867CrossRefPubMedPubMedCentral Bujanda L, Sarasqueta C, Hijona E, Hijona L, Cosme A, Gil I, Elorza JL et al (2010) Colorectal cancer prognosis twenty years later. World J Gastroenterol 16:862–867CrossRefPubMedPubMedCentral
3.
go back to reference Sonnerberg A, Delco F, Inadomi JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133:573–584CrossRef Sonnerberg A, Delco F, Inadomi JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133:573–584CrossRef
4.
go back to reference Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’brien MJ, Levin B et al (2006) Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 56:143–159CrossRefPubMed Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’brien MJ, Levin B et al (2006) Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 56:143–159CrossRefPubMed
5.
go back to reference Levy BT, Dawson J, Hartz AJ, James PA (2006) Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med 31:193–201CrossRefPubMed Levy BT, Dawson J, Hartz AJ, James PA (2006) Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med 31:193–201CrossRefPubMed
6.
go back to reference Grau J, Serradesanferm A, Polbach S, García-Basteiro A, Trilla A, Castells A (2010) Programas de cribado del cáncer colorrectal en la población de riesgo medio en la Unión Europea y España. Gastroenterol Hepatol 33:111–118CrossRefPubMed Grau J, Serradesanferm A, Polbach S, García-Basteiro A, Trilla A, Castells A (2010) Programas de cribado del cáncer colorrectal en la población de riesgo medio en la Unión Europea y España. Gastroenterol Hepatol 33:111–118CrossRefPubMed
7.
go back to reference Peris M, Espinàs JA, Muñoz L, Navarro M, Binefa G, Borràs JM (2007) Catalan Colorectal Cancer Screening Pilot Programme Group. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 14(2):81–86CrossRefPubMed Peris M, Espinàs JA, Muñoz L, Navarro M, Binefa G, Borràs JM (2007) Catalan Colorectal Cancer Screening Pilot Programme Group. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 14(2):81–86CrossRefPubMed
11.
go back to reference Adachi Y, Yasuda K, Kakisako K, Sato K, Shiraishi N, Kitano S (1999) Histopathologic criteria for local excision of colorectal cancer: multivariate analysis. Ann Surg Oncol 6:385–388CrossRefPubMed Adachi Y, Yasuda K, Kakisako K, Sato K, Shiraishi N, Kitano S (1999) Histopathologic criteria for local excision of colorectal cancer: multivariate analysis. Ann Surg Oncol 6:385–388CrossRefPubMed
12.
go back to reference Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Langner C (2011) Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol 34:43–49CrossRefPubMed Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Langner C (2011) Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol 34:43–49CrossRefPubMed
13.
go back to reference Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK et al (2005) Metastatic potential in T1 and T2 colorectal cancer. Hepato-Gastroenterology 52:1688–1691PubMed Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK et al (2005) Metastatic potential in T1 and T2 colorectal cancer. Hepato-Gastroenterology 52:1688–1691PubMed
15.
go back to reference Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28:264–271CrossRefPubMed Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28:264–271CrossRefPubMed
16.
go back to reference O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging. J Natl Cancer Inst 96:1420–1425CrossRefPubMed O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging. J Natl Cancer Inst 96:1420–1425CrossRefPubMed
17.
go back to reference Perea J, Lomas M, Hidalgo M (2011) Bases moleculares del cáncer colorrectal: ¿Hacia un manejo individualizado? Rev EspEnferm. Dig 103:29–35 Perea J, Lomas M, Hidalgo M (2011) Bases moleculares del cáncer colorrectal: ¿Hacia un manejo individualizado? Rev EspEnferm. Dig 103:29–35
18.
go back to reference Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY et al (2008) Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol 97:383–387CrossRefPubMed Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY et al (2008) Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol 97:383–387CrossRefPubMed
19.
go back to reference Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J et al (2001) Guidelines 2000 for Colon and Rectal Cancer Surgery. J Natl Cancer Inst 93:583–596CrossRefPubMed Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J et al (2001) Guidelines 2000 for Colon and Rectal Cancer Surgery. J Natl Cancer Inst 93:583–596CrossRefPubMed
20.
go back to reference Choi HK, Law WL, Poon JT (2010) The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer 10:267–273CrossRefPubMedPubMedCentral Choi HK, Law WL, Poon JT (2010) The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer 10:267–273CrossRefPubMedPubMedCentral
21.
go back to reference Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Color Dis 24:1297–1302CrossRef Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Color Dis 24:1297–1302CrossRef
22.
go back to reference Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW et al (2009) Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J RadiatOncolBiol Phys 74:796–802 Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW et al (2009) Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J RadiatOncolBiol Phys 74:796–802
23.
go back to reference Courtney ED, Chong D, Tighe R, Easterbrook JR, Stebbings WS, Hernon J (2013) Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines. Color Dis 15:177–182CrossRef Courtney ED, Chong D, Tighe R, Easterbrook JR, Stebbings WS, Hernon J (2013) Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines. Color Dis 15:177–182CrossRef
24.
go back to reference Brenner H, Jansen L, Ulrich A, Chang-Claude J, Hoffmeister M (2016) Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget 7(28):44695–44703CrossRefPubMedPubMedCentral Brenner H, Jansen L, Ulrich A, Chang-Claude J, Hoffmeister M (2016) Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget 7(28):44695–44703CrossRefPubMedPubMedCentral
25.
go back to reference Huh JW, Kim HR, Kim YJ (2010) Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol 17:2066–2072CrossRefPubMed Huh JW, Kim HR, Kim YJ (2010) Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol 17:2066–2072CrossRefPubMed
26.
go back to reference Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14:1074–1080CrossRefPubMed Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14:1074–1080CrossRefPubMed
27.
go back to reference Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490CrossRefPubMed Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490CrossRefPubMed
28.
go back to reference Cho YB, Chun HK, Yun HR, Kim HC, Yun SH, Lee WY (2009) Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepato-Gastroenterology 56:1335–1340PubMed Cho YB, Chun HK, Yun HR, Kim HC, Yun SH, Lee WY (2009) Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepato-Gastroenterology 56:1335–1340PubMed
29.
go back to reference Halvorsen TB, Seim E (1988) Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J Clin Pathol 41:532–537CrossRefPubMedPubMedCentral Halvorsen TB, Seim E (1988) Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J Clin Pathol 41:532–537CrossRefPubMedPubMedCentral
30.
go back to reference Derwinger K, Kodeda K, Bexe-Lindskog E, Taflin H (2010) Tumor differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncol 49:57–62CrossRefPubMed Derwinger K, Kodeda K, Bexe-Lindskog E, Taflin H (2010) Tumor differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncol 49:57–62CrossRefPubMed
Metadata
Title
Population-based screening improves histopathological prognostic factors in colorectal cancer
Authors
Mónica Mengual-Ballester
Enrique Pellicer-Franco
Graciela Valero-Navarro
Victoriano Soria-Aledo
José Andrés García-Marín
José Luis Aguayo-Albasini
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 1/2018
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-017-2928-z

Other articles of this Issue 1/2018

International Journal of Colorectal Disease 1/2018 Go to the issue